SANDRENA

This brand name is authorized in Australia, Brazil, United Kingdom

Active ingredients

The drug SANDRENA contains one active pharmaceutical ingredient (API):

1 Estradiol UNII 4TI98Z838E - ESTRADIOL

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. Read about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SANDRENA Gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03CA03	Estradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8286D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 527303501166318, 527303502162316
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 36580, 36588, 36590